MiR‐15a/16 deficiency enhances anti‐tumor immunity of glioma‐infiltrating CD8+ T cells through targeting mTOR
Jiao Yang(Chinese Academy of Sciences), Yiwei Chu(Fudan University), Feifei Luo(Jiangxi University of Traditional Chinese Medicine), Yuedi Wang(Fudan University), Dan Zhang(Fudan University), Ronghua Liu(Agriculture and Agri-Food Canada), Jiawen Qian(Fudan University), Zhou Lu(Fudan University), Yuting Deng(Shanghai Jiao Tong University)
Cited by 82
Related Papers
SIRT5 Desuccinylates and Activates Pyruvate Kinase M2 to Block Macrophage IL-1β Production and to Prevent DSS-Induced Colitis in Mice
|Cell Reports|2017|340
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
|Journal of Neuroinflammation|2018|264
Evaluation of the Stability and Antioxidant Activity of Nanoencapsulated Resveratrol during in Vitro Digestion
|Journal of Agricultural and Food Chemistry|2011|192
Lipid metabolism in inflammation-related diseases
|The Analyst|2018|183
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
|Journal of Hematology & Oncology|2020|183